BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38221665)

  • 1. To study the survival analysis and recurrence pattern in women treated for breast cancer: Retrospective study, a tertiary cancer center experience from Sub-Himalayan Region of India.
    Sundram S; Nandi S; Arora A; Saini S
    J Surg Oncol; 2024 Apr; 129(5):843-849. PubMed ID: 38221665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy.
    Alabdulkareem H; Pinchinat T; Khan S; Landers A; Christos P; Simmons R; Moo TA
    Breast J; 2018 Mar; 24(2):148-153. PubMed ID: 28707744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors of breast cancer recurrence in pathologic complete response achieved by patients following neoadjuvant chemotherapy: a single-center retrospective study.
    Choi JY; Woen D; Jang SY; Lee H; Shin DS; Kwak Y; Lee H; Chae BJ; Yu J; Lee JE; Kim SW; Nam SJ; Ryu JM
    Front Oncol; 2023; 13():1230310. PubMed ID: 37849818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luminal B, Human Epidermal Growth Factor Receptor 2 (HER2/neu), and Triple-Negative Breast Cancers Associated With a Better Chemotherapy Response Than Luminal A Breast Cancers in Postneoadjuvant Settings.
    Hashmi AA; Bukhari U; Najam J; Dowlah T; Ali AH; Diwan MA; Anjali F; Sham S; Zia S; Irfan M
    Cureus; 2023 Jun; 15(6):e40066. PubMed ID: 37425505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy.
    Caudle AS; Yu TK; Tucker SL; Bedrosian I; Litton JK; Gonzalez-Angulo AM; Hoffman K; Meric-Bernstam F; Hunt KK; Buchholz TA; Mittendorf EA
    Breast Cancer Res; 2012 May; 14(3):R83. PubMed ID: 22621334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial and Ethnic Disparities in Locoregional Recurrence Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer: A Post Hoc Analysis of the TAILORx Randomized Clinical Trial.
    Kantor O; King TA; Freedman RA; Mayer EL; Chavez-MacGregor M; Korde LA; Sparano JA; Mittendorf EA
    JAMA Surg; 2023 Jun; 158(6):583-591. PubMed ID: 37043210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within breast cancer subtypes and stages among older women: a SEER-Medicare analysis.
    Zhang H; Barner JC; Moczygemba LR; Rascati KL; Park C; Kodali D
    Breast Cancer; 2023 May; 30(3):489-496. PubMed ID: 36842097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locoregional recurrence patterns in women with breast cancer who have not undergone post-mastectomy radiotherapy.
    Zhao X; Tang Y; Wang S; Yang Y; Fang H; Wang J; Jing H; Zhang J; Sun G; Chen S; Jin J; Song Y; Liu Y; Chen B; Qi S; Li N; Tang Y; Lu N; Ren H; Li Y
    Radiat Oncol; 2020 Sep; 15(1):212. PubMed ID: 32887640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast Cancer Recurrence in the Nipple-Areola Complex After Nipple-Sparing Mastectomy With Immediate Breast Reconstruction for Invasive Breast Cancer.
    Wu ZY; Kim HJ; Lee JW; Chung IY; Kim JS; Lee SB; Son BH; Eom JS; Kim SB; Gong GY; Kim HH; Ahn SH; Ko B
    JAMA Surg; 2019 Nov; 154(11):1030-1037. PubMed ID: 31461141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-World Outcomes Among Older Mexican Women with Breast Cancer Treated with Neoadjuvant Chemotherapy.
    Cabrera-Galeana P; Soto-Perez-de-Celis E; Reynoso-Noveron N; Villarreal-Garza C; Lara-Medina F; Alvarado-Miranda A; Espinosa-Fernandez JR; Esparza-Arias N; Mohar A; Bargallo-Rocha JE
    Oncologist; 2020 Dec; 25(12):1023-1031. PubMed ID: 32275801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
    Wu SY; Tan Y; Guan YS
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metaplastic Breast Carcinoma: Experience of a Tertiary Cancer Center in the Middle East.
    Erjan A; Almasri H; Abdel-Razeq H; Al-Masri M; Haddad H; Alnsour A; Rahman FA; Dayyat A
    Cancer Control; 2021; 28():10732748211004889. PubMed ID: 33827281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer in a tertiary cancer center in India - An audit, with outcome analysis.
    Nair N; Shet T; Parmar V; Havaldar R; Gupta S; Budrukkar A; Sarin R; Thakur M; Desai S; Yadav P; Jalali R; Gulia S; Wadasadawala T; Gosh J; Bajpai J; Kembhavi S; Patil A; Joshi S; Popat P; Rangarajan V; Shah S; Vanmali V; Siddiqui S; Mittra I; Badwe R
    Indian J Cancer; 2018; 55(1):16-22. PubMed ID: 30147088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between systemic immune-inflammation index and neoadjuvant chemotherapy efficacy as well as prognosis in triple-negative breast cancer.
    Pang J; Wang S; Liao L; Liu X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Sept 28; 46(9):958-965. PubMed ID: 34707005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological profile of breast cancer: An institutional experience.
    Gogia A; Deo SV; Shukla NK; Mathur S; Sharma DN; Tiwari A
    Indian J Cancer; 2018; 55(3):210-213. PubMed ID: 30693880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer risk factors, survival and recurrence, and tumor molecular subtype: analysis of 3012 women from an indigenous Asian population.
    Abubakar M; Sung H; Bcr D; Guida J; Tang TS; Pfeiffer RM; Yang XR
    Breast Cancer Res; 2018 Sep; 20(1):114. PubMed ID: 30227867
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.